Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use

NCT00479180 is registered in ClinicalTrials.gov with Pervasis Therapeutics, Inc as lead sponsor.

NCT NCT00479180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00479180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Vascugel Treatment After Creation of Arteriovenous Access for Hemodialysis Use
Lead sponsor
Pervasis Therapeutics, Inc
Phase
Phase 1/2
Overall status
Completed
Start date
July 31, 2006
Completion date
June 30, 2010
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis access